Instrument Inactif

Autres langues Cytomedix, Inc. OTC Bulletin Board

Actions

CMXI

US23283B2043

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

15/05	Nuo Therapeutics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
19/04	Nuo Therapeutics, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Nuo Therapeutics, Inc. announced that it has received $0.650875 million in funding	20/05
Nuo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Nuo Therapeutics, Inc. announced that it expects to receive $0.650875 million in funding	10/05
Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19/04
Exor-backed NUO invests in Italian teenage clothing chain Subdued	19/03
Nuo Therapeutics, Inc. announced that it has received $0.9625 million in funding	19/12
Nuo Therapeutics, Inc. announced that it expects to receive $0.9625 million in funding	08/12
Nuo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20/11
Nuo Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Insider Buy: Nuo Therapeutics	04/08/23
Nuo Therapeutics, Inc. announced that it has received $1.035 million in funding	01/08/23
Nuo Therapeutics, Inc. announced that it expects to receive $1.035 million in funding	26/07/23
Nuo Therapeutics Selects to Exhibit AurixÂ® System At Vizient Innovative Technology Exchange	26/06/23
Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange	26/06/23
Nuo Therapeutics’ Aurix® System Added To Wound Care Formulary Of Wound Care Advantage	22/06/23
Nuo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	17/04/23
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	17/04/23
Nuo Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	17/04/23
NUO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	05/12/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Cytomedix, Inc. OTC Bulletin Board

Actions

CMXI

US23283B2043

Autres langues

Filtres